Page last updated: 2024-08-23

zidovudine and fozivudine tidoxil

zidovudine has been researched along with fozivudine tidoxil in 7 studies

Research

Authors	Studies
Anderson, R; Boerner, D; Diquet, B; Girard, PM; Pegram, PS; Raffi, F; Sereni, D; Tubiana, R	1
Boerner, D; Bogner, JR; Goebel, FD; Herrmann, DB; Hoegl, L; Jost, V; Mühlhöfer, A; Roecken, M; Thoma-Greber, E	1
Boerner, D; Bogner, JR; Goebel, FD; Gürtler, L; Herrmann, DB; Kaufmann, B; Plewig, G; Roecken, M	1
Heckl-Ostreicher, B; Lebrecht, D; Reuss, FU; Venhoff, AC; Venhoff, N; Walker, UA; Wehr, R	1
Fogle, JE; Miller, MM	1
Anglaret, X; Danel, C; Eholie, S; Ello, F; Girard, PM; Hoelscher, M; Kroidl, A; Lennemann, T; Maganga, L; Mgaya, J; Moh, R; Pruvost, A; Saathoff, E; von Massow, F; Zuhse, R	1

1 review(s) available for zidovudine and fozivudine tidoxil

Article	Year
Fozivudine: BM 211290, fozivudine tidoxil, FZT, HDP 990002, W 09726867. Drugs in R&D, 2004, Volume: 5, Issue:1 Topics: Animals; Anti-HIV Agents; Drugs, Investigational; HIV Infections; Humans; Lipids; Zidovudine	2004

4 trial(s) available for zidovudine and fozivudine tidoxil

Article	Year
Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy. Journal of acquired immune deficiency syndromes (1999), 2000, Mar-01, Volume: 23, Issue:3 Topics: Adult; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine	2000
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290). Antiviral therapy, 1997, Volume: 2, Issue:4 Topics: Adult; Anti-HIV Agents; Food; HIV Infections; Humans; Lipids; Male; Middle Aged; Zidovudine	1997
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial. Antiviral therapy, 1997, Volume: 2, Issue:4 Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Lipids; Male; Middle Aged; RNA, Viral; Zidovudine	1997
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire. AIDS (London, England), 2017, 02-20, Volume: 31, Issue:4 Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cote d'Ivoire; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Lipids; Male; Middle Aged; Prospective Studies; Sustained Virologic Response; Tanzania; Treatment Outcome; Zidovudine	2017

2 other study(ies) available for zidovudine and fozivudine tidoxil

Article	Year
Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Animals; Didanosine; DNA, Mitochondrial; Lipids; Liver; Male; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Zidovudine	2009
Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection. Viruses, 2012, Volume: 4, Issue:6 Topics: Animals; Anti-HIV Agents; Cat Diseases; Cats; CD4-CD8 Ratio; Feline Acquired Immunodeficiency Syndrome; Lipids; Lymphocyte Count; Treatment Outcome; Viral Load; Viremia; Zidovudine	2012